AGC Biologics, your friendly CDMO expert, today announced a development and manufacturing services agreement with specialty vaccine company Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) to supply ...

Valneva (VALN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Chikungunya virus disease, a debilitating mosquito-borne (Aedes spp) illness caused by an alphavirus, chikungunya virus, is usually endemic in regions with tropical climates.1 Since the beginning of ...

Valneva SE (VALN) Overview. Read detailed company information including current share prices, financial summary, directors, announcements, dividends & news. Find out more at Intelligent Investor ...

Most of the locally-acquired cases of chikungunya appear to be clustered around two towns near Marseille, Toulon and ...

About Valneva SE We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.

Saint-Herblain, France, June 26, 2025 – Valneva SE, (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world’s ...

About Valneva SE We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly ...

Saint-Herblain (France), June 25, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors ...

Valneva reports positive six-month data for Ixchiq in children, supporting a full dose approach ahead of a Phase 3 trial set for early 2026.

Peter Bühler, Valneva’s Chief Financial Officer, commented, “In the first quarter, we continued to deliver double-digit sales growth and made significant clinical and regulatory progress ...

Valneva will provide a live webcast of its full-year 2024 results conference call beginning at 3 p.m. CET/10 a.m. EDT today. This webcast will also be available on the Company’s website.